Treatment of MS with Copaxone and Albuterol (AMS01)
收藏Mendeley Data2024-06-25 更新2024-06-30 收录
下载链接：
https://www.immport.org/shared/study/SDY471
下载链接
链接失效反馈官方服务：
资源简介：
A randomized, double-masked, 2-arm pilot study of Copaxone and albuterol versus Copaxone and placebo for the treatment of multiple sclerosis. Twenty-four patients with MS who meet the inclusion/exclusion criteria will be enrolled per arm. Each patient will be randomized to receive either 20 mg SQ of Copaxone plus an oral dose of placebo daily or 20 mg SQ of Copaxone plus an oral dose of albuterol daily. Patients will be followed for two years.
创建时间：
2023-06-28
